Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jacqueline Brandwynne Insider Profile
4 Followers
Jacqueline Brandwynne, Director at ImmunoCellular Therapeutics, holds 22.00K shares in ImmunoCellular Therapeutics (Ticker: IMUC), holds 0.00 shares in Microvision (Ticker: MVIS).
Jacqueline Brandwynne has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jacqueline Brandwynne holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jacqueline Brandwynne
Jacqueline Brandwynne's Trading History
ImmunoCellular Therapeutics
May 25, 2012
Director
Uninformative Buy
―
$5.59K
Microvision
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Jacqueline Brandwynne's performance on stock
You May Also Like
Jacqueline Brandwynne insider profile FAQ
What is the percentage of profitable transactions made by Jacqueline Brandwynne?
The percentage of profitable transactions made by Jacqueline Brandwynne is ―.
What is the average return per transaction made by Jacqueline Brandwynne?
The average return per transaction made by Jacqueline Brandwynne is ―.
What stocks does Jacqueline Brandwynne hold?
Jacqueline Brandwynne holds: IMUC, MVIS stocks.
What was Jacqueline Brandwynne’s latest transaction?
Jacqueline Brandwynne latest transaction was an Uninformative Buy of ―.
What was Jacqueline Brandwynne's most profitable transaction?
Jacqueline Brandwynne’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jacqueline Brandwynne's role in ImmunoCellular Therapeutics?
Jacqueline Brandwynne's role in ImmunoCellular Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.